Description

Imidazo[1,2-A]Pyrazin-3(7H)-One, 6-(3-Hydroxyphenyl)-2-[(4-Hydroxyphenyl)Methyl]-8-(Phenylmethyl)- is a complex heterocyclic organic compound featuring a fused imidazopyrazinone core with multiple phenolic and benzyl substituents. This specific molecular architecture makes it a valuable advanced pharmaceutical intermediate and a key building block for medicinal chemistry research. It is primarily sought after by R&D chemists and process development scientists in the pharmaceutical, biotechnology, and fine chemical sectors for the synthesis of novel therapeutic agents.

Application

• Pharmaceutical Intermediate: Serves as a critical precursor in the synthesis of potential drug candidates, particularly those targeting central nervous system (CNS) disorders or acting as kinase inhibitors.
• Medicinal Chemistry Research: Used as a scaffold for structure-activity relationship (SAR) studies and the development of new chemical entities (NCEs) in academic and industrial labs.
• Biochemical Tool Compound: May be utilized in biological assays to study specific enzyme interactions or cellular pathways due to its unique heterocyclic structure.
• Fine Chemical Synthesis: Employed in multi-step organic synthesis for constructing complex molecules with specific pharmacological properties.
• Reference Standard: Supplied as a high-purity compound for analytical method development, validation, and quality control in API manufacturing.

Basic Information

Product Name	Imidazo[1,2-A]Pyrazin-3(7H)-One, 6-(3-Hydroxyphenyl)-2-[(4-Hydroxyphenyl)Methyl]-8-(Phenylmethyl)-
CAS No.	123437-49-0
Molecular Formula	C26H21N3O3
Molecular Weight	423.47 g/mol
Synonyms	6-(3-Hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-8-(phenylmethyl)imidazo[1,2-a]pyrazin-3(7H)-one; 2-[(4-Hydroxybenzyl)-8-benzyl-6-(3-hydroxyphenyl)imidazo[1,2-a]pyrazin-3-one; 8-Benzyl-6-(3-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]imidazo[1,2-a]pyrazin-3(7H)-one; Imidazo[1,2-a]pyrazin-3(7H)-one, 6-(3-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-8-(phenylmethyl)-; CAS 123437-49-0
EINECS	Contact for details

Quality Control

Our high-purity pharmaceutical intermediate is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and spectroscopic identification (NMR, MS), to ensure it meets exacting R&D and process chemistry standards. A comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). This compound may be light-sensitive and hygroscopic; therefore, handling under an inert atmosphere is recommended for long-term storage to maintain stability.

Specification

Item	Specification
Appearance	Off-white to light yellow powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥97.0% (Area Percent)
Water Content (KF)	≤0.5%
Residue on Ignition	≤0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.